London Technology Fund

London Technology Fund is a venture capital firm in  England that focuses on investing in technology-driven companies. Founded 2005 in London, England, United Kingdom, it invests in early stage ventures and series A. Its portfolio companies include Novacem, Immune Targeting Systems, ApplianSys, and deltaDOT. As of June 2020, London Technology Fund has made six investments. Their most recent investment was on January 27, 2011, when Novacem raised £1.5M. London Technology Fund has had one exit, which was Immune Targeting Systems. London Technology Fund also invests in the technology, communications, software, electronics, biotechnology, medical, energy, environment, physical sciences, materials and manufacturing sectors.